Potential prevention of neural tube defects by assessment of women of childbearing age through monitoring of folate

Three quarters of neural tube defects (NTD) can be prevented by sufficient dietary folate supplementation. Despite this knowledge, most women do not supplement their diet effectively. Red cell folate concentrations correlate with the risk of NTD, and levels of less than 900 nM are associated with an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Therapeutic drug monitoring 2002-10, Vol.24 (5), p.628-630
Hauptverfasser: KAPUR, Bhushan, SOLDIN, Offie Porat, KOREN, Gideon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 630
container_issue 5
container_start_page 628
container_title Therapeutic drug monitoring
container_volume 24
creator KAPUR, Bhushan
SOLDIN, Offie Porat
KOREN, Gideon
description Three quarters of neural tube defects (NTD) can be prevented by sufficient dietary folate supplementation. Despite this knowledge, most women do not supplement their diet effectively. Red cell folate concentrations correlate with the risk of NTD, and levels of less than 900 nM are associated with an increased risk of these serious congenital anomalies. Laboratory tests to assess anemia include testing for folate. This study was conducted to estimate the potential benefits of informing women of reproductive age who are unaware of their low folate levels, uncovered in their anemia tests. The number of Ontario women of reproductive age who undergo folate tests and are at an increased risk of NTD was calculated. In addition, the authors calculated the number of NTD cases that could have been prevented if these women were informed of the possible consequences of their low folate levels should they become pregnant. In 1998, red cell folate concentrations were measured in 23,109 women of childbearing age (15-45 y). Approximately half of the women [n = 11,392 (49.3%)] had folate levels below 900 nM and thus were at an increased risk of giving birth to a child with NTD should they have become pregnant. Their overall mean relative risk (RR) of NTD was 1.95, or 1:512 births. If they would have been informed of this risk and subsequently increased their consumption of folate before becoming pregnant, 22.3 cases of NTD per year could have possibly been prevented at no extra cost, since the folic acid results were a part of investigational blood tests performed for another reason (anemia). Women of reproductive age who are being evaluated for the cause of anemia and have low red cell folate results constitute a high-risk group for NTD in their children. These women should be informed of the increased risk and of methods of dietary folate supplementation.
doi_str_mv 10.1097/00007691-200210000-00008
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3635838</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72129060</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-bd34fb909313d63ba68e632cc3c80a19a2166435a1744b14435f8e124995ddfd3</originalsourceid><addsrcrecordid>eNpVkctu3CAUhlHVqpkkfYWKTbtzChzMwKZSFfUmRUoWzRphfDxDZZsp4FR5--JkmrQs4OfwcS76CaGcXXBmth9YXVtleCMYE3y9NeumX5ANb0E1oIx8STaMK2gktOqEnOb8kzEuNWOvyQkX0AoDckPyTSw4l-BGekh4t8o40zjQGZdUg2XpkPY4oC-ZdvfU5Yw5T5Vbod-xqlX4fRj7Dl0K8466HdKyT3HZ7ekU51DiQ7hiQxxdwXPyanBjxjfH84zcfvn84_Jbc3X99fvlp6vGS6lK0_Ugh84wAxx6BZ1TGhUI78Fr5rhxgitVp3N8K2XHZZWDRi6kMW3fDz2ckY-PeQ9LN2Hva9N1JHtIYXLp3kYX7P8vc9jbXbyzoKDVoGuC98cEKf5aMBc7hexxHN2Mccl2K7gwTLEK6kfQp5hzwuGpCGd2dcz-dcw-OfYQWmu8_bfJ549Hiyrw7gi47N04JDf7kJ85MKC0UPAHUm6gyw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72129060</pqid></control><display><type>article</type><title>Potential prevention of neural tube defects by assessment of women of childbearing age through monitoring of folate</title><source>Journals@Ovid Ovid Autoload</source><source>MEDLINE</source><creator>KAPUR, Bhushan ; SOLDIN, Offie Porat ; KOREN, Gideon</creator><creatorcontrib>KAPUR, Bhushan ; SOLDIN, Offie Porat ; KOREN, Gideon</creatorcontrib><description>Three quarters of neural tube defects (NTD) can be prevented by sufficient dietary folate supplementation. Despite this knowledge, most women do not supplement their diet effectively. Red cell folate concentrations correlate with the risk of NTD, and levels of less than 900 nM are associated with an increased risk of these serious congenital anomalies. Laboratory tests to assess anemia include testing for folate. This study was conducted to estimate the potential benefits of informing women of reproductive age who are unaware of their low folate levels, uncovered in their anemia tests. The number of Ontario women of reproductive age who undergo folate tests and are at an increased risk of NTD was calculated. In addition, the authors calculated the number of NTD cases that could have been prevented if these women were informed of the possible consequences of their low folate levels should they become pregnant. In 1998, red cell folate concentrations were measured in 23,109 women of childbearing age (15-45 y). Approximately half of the women [n = 11,392 (49.3%)] had folate levels below 900 nM and thus were at an increased risk of giving birth to a child with NTD should they have become pregnant. Their overall mean relative risk (RR) of NTD was 1.95, or 1:512 births. If they would have been informed of this risk and subsequently increased their consumption of folate before becoming pregnant, 22.3 cases of NTD per year could have possibly been prevented at no extra cost, since the folic acid results were a part of investigational blood tests performed for another reason (anemia). Women of reproductive age who are being evaluated for the cause of anemia and have low red cell folate results constitute a high-risk group for NTD in their children. These women should be informed of the increased risk and of methods of dietary folate supplementation.</description><identifier>ISSN: 0163-4356</identifier><identifier>EISSN: 1536-3694</identifier><identifier>DOI: 10.1097/00007691-200210000-00008</identifier><identifier>PMID: 12352934</identifier><identifier>CODEN: TDMODV</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adolescent ; Adult ; Age Factors ; Biological and medical sciences ; Female ; Folic Acid - blood ; Folic Acid - therapeutic use ; Gynecology. Andrology. Obstetrics ; Humans ; Management. Prenatal diagnosis ; Medical sciences ; Middle Aged ; Neural Tube Defects - diet therapy ; Neural Tube Defects - prevention &amp; control ; Pregnancy. Fetus. Placenta</subject><ispartof>Therapeutic drug monitoring, 2002-10, Vol.24 (5), p.628-630</ispartof><rights>2003 INIST-CNRS</rights><rights>2002 Lippincott Williams &amp; Wilkins, Inc., Philadelphia 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-bd34fb909313d63ba68e632cc3c80a19a2166435a1744b14435f8e124995ddfd3</citedby><cites>FETCH-LOGICAL-c446t-bd34fb909313d63ba68e632cc3c80a19a2166435a1744b14435f8e124995ddfd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13936826$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12352934$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KAPUR, Bhushan</creatorcontrib><creatorcontrib>SOLDIN, Offie Porat</creatorcontrib><creatorcontrib>KOREN, Gideon</creatorcontrib><title>Potential prevention of neural tube defects by assessment of women of childbearing age through monitoring of folate</title><title>Therapeutic drug monitoring</title><addtitle>Ther Drug Monit</addtitle><description>Three quarters of neural tube defects (NTD) can be prevented by sufficient dietary folate supplementation. Despite this knowledge, most women do not supplement their diet effectively. Red cell folate concentrations correlate with the risk of NTD, and levels of less than 900 nM are associated with an increased risk of these serious congenital anomalies. Laboratory tests to assess anemia include testing for folate. This study was conducted to estimate the potential benefits of informing women of reproductive age who are unaware of their low folate levels, uncovered in their anemia tests. The number of Ontario women of reproductive age who undergo folate tests and are at an increased risk of NTD was calculated. In addition, the authors calculated the number of NTD cases that could have been prevented if these women were informed of the possible consequences of their low folate levels should they become pregnant. In 1998, red cell folate concentrations were measured in 23,109 women of childbearing age (15-45 y). Approximately half of the women [n = 11,392 (49.3%)] had folate levels below 900 nM and thus were at an increased risk of giving birth to a child with NTD should they have become pregnant. Their overall mean relative risk (RR) of NTD was 1.95, or 1:512 births. If they would have been informed of this risk and subsequently increased their consumption of folate before becoming pregnant, 22.3 cases of NTD per year could have possibly been prevented at no extra cost, since the folic acid results were a part of investigational blood tests performed for another reason (anemia). Women of reproductive age who are being evaluated for the cause of anemia and have low red cell folate results constitute a high-risk group for NTD in their children. These women should be informed of the increased risk and of methods of dietary folate supplementation.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Folic Acid - blood</subject><subject>Folic Acid - therapeutic use</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Management. Prenatal diagnosis</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neural Tube Defects - diet therapy</subject><subject>Neural Tube Defects - prevention &amp; control</subject><subject>Pregnancy. Fetus. Placenta</subject><issn>0163-4356</issn><issn>1536-3694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkctu3CAUhlHVqpkkfYWKTbtzChzMwKZSFfUmRUoWzRphfDxDZZsp4FR5--JkmrQs4OfwcS76CaGcXXBmth9YXVtleCMYE3y9NeumX5ANb0E1oIx8STaMK2gktOqEnOb8kzEuNWOvyQkX0AoDckPyTSw4l-BGekh4t8o40zjQGZdUg2XpkPY4oC-ZdvfU5Yw5T5Vbod-xqlX4fRj7Dl0K8466HdKyT3HZ7ekU51DiQ7hiQxxdwXPyanBjxjfH84zcfvn84_Jbc3X99fvlp6vGS6lK0_Ugh84wAxx6BZ1TGhUI78Fr5rhxgitVp3N8K2XHZZWDRi6kMW3fDz2ckY-PeQ9LN2Hva9N1JHtIYXLp3kYX7P8vc9jbXbyzoKDVoGuC98cEKf5aMBc7hexxHN2Mccl2K7gwTLEK6kfQp5hzwuGpCGd2dcz-dcw-OfYQWmu8_bfJ549Hiyrw7gi47N04JDf7kJ85MKC0UPAHUm6gyw</recordid><startdate>20021001</startdate><enddate>20021001</enddate><creator>KAPUR, Bhushan</creator><creator>SOLDIN, Offie Porat</creator><creator>KOREN, Gideon</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20021001</creationdate><title>Potential prevention of neural tube defects by assessment of women of childbearing age through monitoring of folate</title><author>KAPUR, Bhushan ; SOLDIN, Offie Porat ; KOREN, Gideon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-bd34fb909313d63ba68e632cc3c80a19a2166435a1744b14435f8e124995ddfd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Folic Acid - blood</topic><topic>Folic Acid - therapeutic use</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Management. Prenatal diagnosis</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neural Tube Defects - diet therapy</topic><topic>Neural Tube Defects - prevention &amp; control</topic><topic>Pregnancy. Fetus. Placenta</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KAPUR, Bhushan</creatorcontrib><creatorcontrib>SOLDIN, Offie Porat</creatorcontrib><creatorcontrib>KOREN, Gideon</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Therapeutic drug monitoring</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KAPUR, Bhushan</au><au>SOLDIN, Offie Porat</au><au>KOREN, Gideon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potential prevention of neural tube defects by assessment of women of childbearing age through monitoring of folate</atitle><jtitle>Therapeutic drug monitoring</jtitle><addtitle>Ther Drug Monit</addtitle><date>2002-10-01</date><risdate>2002</risdate><volume>24</volume><issue>5</issue><spage>628</spage><epage>630</epage><pages>628-630</pages><issn>0163-4356</issn><eissn>1536-3694</eissn><coden>TDMODV</coden><abstract>Three quarters of neural tube defects (NTD) can be prevented by sufficient dietary folate supplementation. Despite this knowledge, most women do not supplement their diet effectively. Red cell folate concentrations correlate with the risk of NTD, and levels of less than 900 nM are associated with an increased risk of these serious congenital anomalies. Laboratory tests to assess anemia include testing for folate. This study was conducted to estimate the potential benefits of informing women of reproductive age who are unaware of their low folate levels, uncovered in their anemia tests. The number of Ontario women of reproductive age who undergo folate tests and are at an increased risk of NTD was calculated. In addition, the authors calculated the number of NTD cases that could have been prevented if these women were informed of the possible consequences of their low folate levels should they become pregnant. In 1998, red cell folate concentrations were measured in 23,109 women of childbearing age (15-45 y). Approximately half of the women [n = 11,392 (49.3%)] had folate levels below 900 nM and thus were at an increased risk of giving birth to a child with NTD should they have become pregnant. Their overall mean relative risk (RR) of NTD was 1.95, or 1:512 births. If they would have been informed of this risk and subsequently increased their consumption of folate before becoming pregnant, 22.3 cases of NTD per year could have possibly been prevented at no extra cost, since the folic acid results were a part of investigational blood tests performed for another reason (anemia). Women of reproductive age who are being evaluated for the cause of anemia and have low red cell folate results constitute a high-risk group for NTD in their children. These women should be informed of the increased risk and of methods of dietary folate supplementation.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>12352934</pmid><doi>10.1097/00007691-200210000-00008</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0163-4356
ispartof Therapeutic drug monitoring, 2002-10, Vol.24 (5), p.628-630
issn 0163-4356
1536-3694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3635838
source Journals@Ovid Ovid Autoload; MEDLINE
subjects Adolescent
Adult
Age Factors
Biological and medical sciences
Female
Folic Acid - blood
Folic Acid - therapeutic use
Gynecology. Andrology. Obstetrics
Humans
Management. Prenatal diagnosis
Medical sciences
Middle Aged
Neural Tube Defects - diet therapy
Neural Tube Defects - prevention & control
Pregnancy. Fetus. Placenta
title Potential prevention of neural tube defects by assessment of women of childbearing age through monitoring of folate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T21%3A45%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potential%20prevention%20of%20neural%20tube%20defects%20by%20assessment%20of%20women%20of%20childbearing%20age%20through%20monitoring%20of%20folate&rft.jtitle=Therapeutic%20drug%20monitoring&rft.au=KAPUR,%20Bhushan&rft.date=2002-10-01&rft.volume=24&rft.issue=5&rft.spage=628&rft.epage=630&rft.pages=628-630&rft.issn=0163-4356&rft.eissn=1536-3694&rft.coden=TDMODV&rft_id=info:doi/10.1097/00007691-200210000-00008&rft_dat=%3Cproquest_pubme%3E72129060%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72129060&rft_id=info:pmid/12352934&rfr_iscdi=true